|
Room 100 The Keck Center of The National Academies 500 Fifth Street, NW Washington, DC 20001
February 18, 2003 8:00a.m. to 4:45p.m.
The Workshop is Free and Open to the Public
8:00 Continental Breakfast
8:25 Welcome and Introduction Ed Penhoet, Committee Chair
8:30 (Unable to Attend) Better Information and Decision Tools: The Needs of the Consumer Mary Ropka, University of Virginia Medical School
9:00 (Unable to Attend) Decision Support in Breast Cancer Detection Nananda Col, Brigham and Women’s Hospital
9:30 DISCUSSION
9:45 Marketing Strategies: How Companies Work to Encourage Adoption of New Medical Technologies Laura Shapiro, Siemens Medical Solutions
10:15 (Unable to Attend) Research and Development Strategies in Molecular Imaging Technologies H. Donald Burns, Merck
10:45 DICUSSION
11:00 BREAK
11:15 (Unable to Attend) NCI Programs to Support Development of New Approaches to Breast Cancer Detection Ed Staab, National Cancer Institute
11:45 (Unable to Attend) DoD’s Breast Cancer Research Program COL Melissa Forsythe, DoD Breast Cancer Research Program
12:15 DISCUSSION
12:30 LUNCH
1:15 (Unable to Attend) Challenges in Assessing the Safety and Efficacy of Cancer Detection Devices David Feigal, CDRH, FDA
1:45 (Unable to Attend) Regulatory Challenges for In Vitro Diagnostics Joseph Hackett, CDRH, FDA
2:15 (Unable to Attend) CMS Perspective on Adoption of New Breast Cancer Detection Technologies Sean Tunis, Centers for Medicare and Medicaid Services
2:45 DISCUSSION
3:00 BREAK
3:15 The Role of Innovative Not-for-Profits in Medical Innovation: Lessons from CaP CURE Howard Soule, CaP CURE
3:45 The Role of Breast Cancer Philanthropies in Developing New Approaches to Breast Cancer Detection Susan Braun, Susan G. Komen Foundation
4:15 DISCUSSION
4:45 ADJOURN
|